Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

I. Tzoran, M. Papadakis, B. Brenner, Á. Fidalgo, A. Rivas, P.S. Wells, O. Gavín, M.D. Adarraga, F. Moustafa, M. Monreal, H. Decousus, P. Prandoni, R. Barba, P. Di Micco, L. Bertoletti, A. Reis, M. Bosevski, H. Bounameaux, R. Malý, P. WellsM.A. Aibar, M. Alfonso, J.I. Arcelus, M. Barrón, B. Barrón-Andrés, J. Bascuñana, A. Blanco-Molina, T. Bueso, G. Cañada, I. Cañas, N. Chic, R. del Pozo, J. del Toro, M.C. Díaz-Pedroche, J.A. Díaz-Peromingo, C. Falgá, C. Fernández-Capitán, M.A. Fidalgo, C. Font, L. Font, P. Gallego, A. García, M.A. García, F. García-Bragado, A. Lorenzo, G. Antonucci, P. Ferrazzi, E. Grandone, C. Lodigiani, L. Rota

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation'. Together they form a unique fingerprint.

Medicine & Life Sciences